Davis C Woodworth, Jerry J Lou, William H Yong, Elizabeth Head, María M Corrada, Peter T Nelson, S Ahmad Sajjadi
{"title":"老年海马硬化的常见神经病理改变驱动因素","authors":"Davis C Woodworth, Jerry J Lou, William H Yong, Elizabeth Head, María M Corrada, Peter T Nelson, S Ahmad Sajjadi","doi":"10.1093/brain/awaf158","DOIUrl":null,"url":null,"abstract":"Hippocampal sclerosis of aging (HS-A) –severe cell loss and gliosis in the hippocampal formation– is a neuropathologic change (NC) that affects up to 20% of elderly persons with dementia. The etiology of HS-A is heterogeneous, but HS-A is strongly associated with limbic-predominant age-related TDP-43 encephalopathy NC (LATE-NC). Other NCs have also been implicated in relation to HS-A, but these associations have been inconsistent across previous studies. Also, because LATE-NC and HS-A are so strongly associated, it is important to adjust for LATE-NC when examining associations between other NCs and HS-A. The goal of this study was to examine associations of other common NCs with HS-A, both before and after adjusting for LATE-NC. We analyzed the National Alzheimer’s Coordinating Center (NACC) neuropathology dataset and examined associations of Alzheimer’s disease NC (ADNC), Lewy bodies (LB), and cerebrovascular NCs, with HS-A, adjusting for LATE-NC in multiple ways. We used Bayesian multilevel logistic regression models with monotonic modeling for ordinal predictors, and report the odds ratios (OR) or average OR across levels (aOR) along with 95% credibility intervals (CI) as well as expected frequencies of HS-A for selected models and predictor levels. Of n=1933 autopsy participants included (average age at death of 83 years, 51.3% women), HS-A was present in 278 (14.4%). LATE-NC was strongly associated with HS-A (aOR=3.7, 95% CI=[2.8, 5.0]). While ADNC showed a modest association with HS-A in models where LATE-NC was not included as a predictor (aOR=1.4, CI=[1.1, 1.8]), this association was reduced when adjusting for LATE-NC (aOR=1.11, CI=[0.9, 1.5]); results were similar for the ADNC-related A/B/C scores and limbic LBs. However, several cerebrovascular NCs were similarly associated with HS-A both without adjusting for LATE-NC (atherosclerosis aOR=1.4, arteriolosclerosis aOR=1.6, white matter rarefaction (WMR) aOR=1.4) and with adjusting for LATE-NC (atherosclerosis aOR=1.4, arteriolosclerosis aOR=1.5, WMR aOR=1.3). In a combined model, LATE-NC was strongly associated with HS-A, but global cerebrovascular NCs, as well as APOE-ε4 (increased odds), and education (decreased odds), were also associated with HS-A. Predicted HS-A frequency for predictor levels of no LATE-NC or global cerebrovascular NCs was 1.5% (CI=[0.6%, 3.1%]), while it was 94.5% (CI=[84%, 99.5%]) for LATE-NC stage 3 and severe global cerebrovascular NC levels. LATE-NC is likely the most important cause of HS-A. While ADNC seems to be associated with HS-A through its association with LATE-NC, the association of cerebrovascular with HS-A independent of LATE-NC underlines the importance of vascular factors in the etiology of HS-A.","PeriodicalId":9063,"journal":{"name":"Brain","volume":"14 1","pages":""},"PeriodicalIF":10.6000,"publicationDate":"2025-05-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Common neuropathologic change drivers of hippocampal sclerosis of ageing\",\"authors\":\"Davis C Woodworth, Jerry J Lou, William H Yong, Elizabeth Head, María M Corrada, Peter T Nelson, S Ahmad Sajjadi\",\"doi\":\"10.1093/brain/awaf158\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Hippocampal sclerosis of aging (HS-A) –severe cell loss and gliosis in the hippocampal formation– is a neuropathologic change (NC) that affects up to 20% of elderly persons with dementia. The etiology of HS-A is heterogeneous, but HS-A is strongly associated with limbic-predominant age-related TDP-43 encephalopathy NC (LATE-NC). Other NCs have also been implicated in relation to HS-A, but these associations have been inconsistent across previous studies. Also, because LATE-NC and HS-A are so strongly associated, it is important to adjust for LATE-NC when examining associations between other NCs and HS-A. The goal of this study was to examine associations of other common NCs with HS-A, both before and after adjusting for LATE-NC. We analyzed the National Alzheimer’s Coordinating Center (NACC) neuropathology dataset and examined associations of Alzheimer’s disease NC (ADNC), Lewy bodies (LB), and cerebrovascular NCs, with HS-A, adjusting for LATE-NC in multiple ways. We used Bayesian multilevel logistic regression models with monotonic modeling for ordinal predictors, and report the odds ratios (OR) or average OR across levels (aOR) along with 95% credibility intervals (CI) as well as expected frequencies of HS-A for selected models and predictor levels. Of n=1933 autopsy participants included (average age at death of 83 years, 51.3% women), HS-A was present in 278 (14.4%). LATE-NC was strongly associated with HS-A (aOR=3.7, 95% CI=[2.8, 5.0]). While ADNC showed a modest association with HS-A in models where LATE-NC was not included as a predictor (aOR=1.4, CI=[1.1, 1.8]), this association was reduced when adjusting for LATE-NC (aOR=1.11, CI=[0.9, 1.5]); results were similar for the ADNC-related A/B/C scores and limbic LBs. However, several cerebrovascular NCs were similarly associated with HS-A both without adjusting for LATE-NC (atherosclerosis aOR=1.4, arteriolosclerosis aOR=1.6, white matter rarefaction (WMR) aOR=1.4) and with adjusting for LATE-NC (atherosclerosis aOR=1.4, arteriolosclerosis aOR=1.5, WMR aOR=1.3). In a combined model, LATE-NC was strongly associated with HS-A, but global cerebrovascular NCs, as well as APOE-ε4 (increased odds), and education (decreased odds), were also associated with HS-A. Predicted HS-A frequency for predictor levels of no LATE-NC or global cerebrovascular NCs was 1.5% (CI=[0.6%, 3.1%]), while it was 94.5% (CI=[84%, 99.5%]) for LATE-NC stage 3 and severe global cerebrovascular NC levels. LATE-NC is likely the most important cause of HS-A. While ADNC seems to be associated with HS-A through its association with LATE-NC, the association of cerebrovascular with HS-A independent of LATE-NC underlines the importance of vascular factors in the etiology of HS-A.\",\"PeriodicalId\":9063,\"journal\":{\"name\":\"Brain\",\"volume\":\"14 1\",\"pages\":\"\"},\"PeriodicalIF\":10.6000,\"publicationDate\":\"2025-05-05\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Brain\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1093/brain/awaf158\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"CLINICAL NEUROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Brain","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/brain/awaf158","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
Common neuropathologic change drivers of hippocampal sclerosis of ageing
Hippocampal sclerosis of aging (HS-A) –severe cell loss and gliosis in the hippocampal formation– is a neuropathologic change (NC) that affects up to 20% of elderly persons with dementia. The etiology of HS-A is heterogeneous, but HS-A is strongly associated with limbic-predominant age-related TDP-43 encephalopathy NC (LATE-NC). Other NCs have also been implicated in relation to HS-A, but these associations have been inconsistent across previous studies. Also, because LATE-NC and HS-A are so strongly associated, it is important to adjust for LATE-NC when examining associations between other NCs and HS-A. The goal of this study was to examine associations of other common NCs with HS-A, both before and after adjusting for LATE-NC. We analyzed the National Alzheimer’s Coordinating Center (NACC) neuropathology dataset and examined associations of Alzheimer’s disease NC (ADNC), Lewy bodies (LB), and cerebrovascular NCs, with HS-A, adjusting for LATE-NC in multiple ways. We used Bayesian multilevel logistic regression models with monotonic modeling for ordinal predictors, and report the odds ratios (OR) or average OR across levels (aOR) along with 95% credibility intervals (CI) as well as expected frequencies of HS-A for selected models and predictor levels. Of n=1933 autopsy participants included (average age at death of 83 years, 51.3% women), HS-A was present in 278 (14.4%). LATE-NC was strongly associated with HS-A (aOR=3.7, 95% CI=[2.8, 5.0]). While ADNC showed a modest association with HS-A in models where LATE-NC was not included as a predictor (aOR=1.4, CI=[1.1, 1.8]), this association was reduced when adjusting for LATE-NC (aOR=1.11, CI=[0.9, 1.5]); results were similar for the ADNC-related A/B/C scores and limbic LBs. However, several cerebrovascular NCs were similarly associated with HS-A both without adjusting for LATE-NC (atherosclerosis aOR=1.4, arteriolosclerosis aOR=1.6, white matter rarefaction (WMR) aOR=1.4) and with adjusting for LATE-NC (atherosclerosis aOR=1.4, arteriolosclerosis aOR=1.5, WMR aOR=1.3). In a combined model, LATE-NC was strongly associated with HS-A, but global cerebrovascular NCs, as well as APOE-ε4 (increased odds), and education (decreased odds), were also associated with HS-A. Predicted HS-A frequency for predictor levels of no LATE-NC or global cerebrovascular NCs was 1.5% (CI=[0.6%, 3.1%]), while it was 94.5% (CI=[84%, 99.5%]) for LATE-NC stage 3 and severe global cerebrovascular NC levels. LATE-NC is likely the most important cause of HS-A. While ADNC seems to be associated with HS-A through its association with LATE-NC, the association of cerebrovascular with HS-A independent of LATE-NC underlines the importance of vascular factors in the etiology of HS-A.
期刊介绍:
Brain, a journal focused on clinical neurology and translational neuroscience, has been publishing landmark papers since 1878. The journal aims to expand its scope by including studies that shed light on disease mechanisms and conducting innovative clinical trials for brain disorders. With a wide range of topics covered, the Editorial Board represents the international readership and diverse coverage of the journal. Accepted articles are promptly posted online, typically within a few weeks of acceptance. As of 2022, Brain holds an impressive impact factor of 14.5, according to the Journal Citation Reports.